ℹ️
🇬🇧
Search
Search for people relevant for "prognóza"
prognóza
Person
Class
Person
Publication
Programmes
Export current view
doc. MUDr. David Belada Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
350 publications
Publications
publication
Prognostic markers in chronic lymphocytic leukemia
2011 |
Faculty of Medicine in Hradec Králové
publication
Malignant lymphomas of non-Hodgkin type in the annals in Department of Dentistry in Hradec Králové 1998-2008
2011 |
Faculty of Medicine in Hradec Králové
publication
Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance
+1
2007 |
Faculty of Medicine in Hradec Králové
publication
Bone marrow/peripheral blood positivity of Bcl-2/IgH rearrangement in patients with follicular lymphoma before treatment has no prognostic significance
2007 |
Publication without faculty affiliation
publication
Achievement of Bcl-2/IgH negativity in peripheral blood/bone marrow is associated with better clinical outcome in patients with follicular lymphoma
2007 |
Publication without faculty affiliation
publication
Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study
2024 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Pharmacy in Hradec Králové
publication
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
publication
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory follicular lymphoma (CITADEL-203): a phase 2 study
2023 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
Load more publications (340)
Loading network view...